These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20487441)

  • 21. Creutzfeldt-Jakob disease.
    Oney D
    Pulse; 1999; 36(2):22. PubMed ID: 10614475
    [No Abstract]   [Full Text] [Related]  

  • 22. Transfusion safety with regards to prions: ethical, legal and societal considerations.
    Turner M
    Transfus Clin Biol; 2006 Nov; 13(5):317-9. PubMed ID: 17196417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion-related vCJD: prevention strategies for prion transmission.
    Holland PV
    Lijec Vjesn; 2007 May; 129 Suppl 3():46. PubMed ID: 18959066
    [No Abstract]   [Full Text] [Related]  

  • 25. Is Creutzfeldt-Jakob disease transmitted in blood? Is the absence of evidence of risk evidence of the absence of risk?
    Ricketts MN
    CMAJ; 1997 Nov; 157(10):1367-70. PubMed ID: 9371066
    [No Abstract]   [Full Text] [Related]  

  • 26. ["Variant Creutzfeld-Jakob Disease and Ophthalmologic Surgery" Committee of the German Society of Ophthalmologic Surgeons advises: current information on application of "Variant Creutzfeld-Jakob Disease Guidelines" of the Robert Koch Institute to ophthalmologic surgery].
    Lemmen KD
    Klin Monbl Augenheilkd; 2003 May; 220(5):366-8. PubMed ID: 12838933
    [No Abstract]   [Full Text] [Related]  

  • 27. [Veterinary and epidemiologic aspects of prion infections].
    Makarov VV
    Vestn Ross Akad Med Nauk; 2003; (1):35-40. PubMed ID: 12608083
    [No Abstract]   [Full Text] [Related]  

  • 28. Creutzfeld-Jakob disease: what we know.
    Darlington J
    Leadersh Health Serv; 1996; 5(6):44-5. PubMed ID: 10163984
    [No Abstract]   [Full Text] [Related]  

  • 29. Infectivity in the blood of mice with a BSE-derived agent.
    Taylor DM; Fernie K; Reichl HE; Somerville RA
    J Hosp Infect; 2000 Sep; 46(1):78-9. PubMed ID: 11023729
    [No Abstract]   [Full Text] [Related]  

  • 30. Government confirms second case of vCJD transmitted by blood transfusion.
    Pincock S
    BMJ; 2004 Jul; 329(7460):251. PubMed ID: 15284140
    [No Abstract]   [Full Text] [Related]  

  • 31. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 32. Creutzfeldt-Jakob disease and blood transfusion.
    Fernandez Lopez MJ; Van Everbroeck B; Pals P; Martin JJ; Cras P
    Acta Neurol Belg; 1998 Sep; 98(3):247-51. PubMed ID: 9801705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Creutzfeldt-Jakob disease and pregnancy].
    Berrebi A; Cohen M; Ayoubi JM
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(8):755-9. PubMed ID: 9509315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to reduce transfusion acquired vCJD.
    Wallis JP
    Transfus Med; 2011 Feb; 21(1):1-6. PubMed ID: 21070399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NBA/NBS perspective on nvCJD.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):329-30. PubMed ID: 10351146
    [No Abstract]   [Full Text] [Related]  

  • 38. From nannyism to public disclosure: the BSE inquiry report.
    CMAJ; 2001 Jan; 164(2):165, 167. PubMed ID: 11332300
    [No Abstract]   [Full Text] [Related]  

  • 39. Bovine spongiform encephalopathy in the United States--an epidemiologist's view.
    Donnelly CA
    N Engl J Med; 2004 Feb; 350(6):539-42. PubMed ID: 14762179
    [No Abstract]   [Full Text] [Related]  

  • 40. Implications of notifying donors and recipients.
    Hewitt PE
    Vox Sang; 2004 Jul; 87 Suppl 2():1-2. PubMed ID: 15209865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.